vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported $9.00 thousand in sales this quarter. This is the same as the same period last year.
Civista Bancshares Names Ian Whinnem Chief Financial Officer, Effective June 3, 2024
Civista Bancshares, Inc. ("Civista") (NASDAQ:CIVB) announced today that Ian Whinnem will join the Company as Senior Vice President, Chief Financial Officer effective June 3, 2024. He will be a member of Civista's
